Tag Archives: abmd

Abiomed, Cambrex Show Why Bigger Isn’t Always Better

Smaller companies like NutriSystem (NTRI) are often nimble and growing at a faster pace than their larger peers. Today’s Screen Of The Day is Small-Cap Leaders, highly rated companies in the S&P SmallCap 600 stock index. The list includes four companies in the hot medical products and health care sector. Abiomed Danvers, Mass.-based Abiomed (ABMD) crushed quarterly estimates on Aug. 4, reporting fiscal first-quarter earnings per

Regeneron, Abiomed Surge On Strong Quarters, Guidance

Top-rated medical stocks Regeneron Pharmaceuticals (REGN) and Abiomed (ABMD) both hit new highs on the stock market early Tuesday after both companies beat quarterly earnings estimates and raised guidance. Regeneron reported Q2 earnings of $2.89 a share excluding one-time items, up 17% from the year-earlier quarter and 12 cents above analysts’ consensus, according to Thomson Reuters. Revenue jumped 50% to $999 million, $11 million above consensus.

Abiomed, Mallinckrodt, Zoetis Beat Q1 Estimates

Three very different but similarly high-rated medical stocks reported strong quarterly earnings Tuesday morning, driving up stocks all around. The smallest but hottest was device maker Abiomed (ABMD), which jumped 15% to a new high near 75 in early trading after soundly beating Wall Street’s expectations and raising its guidance. A bit later, Abiomed stock was up 11%, near 72.50. Abiomed’s earnings in fiscal Q4 ended March 31 totaled 28 cents a